A5014437255- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Coronary Interventions and Diagnostics
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Congenital Heart Disease Studies
- Aortic aneurysm repair treatments
- Cardiac Arrhythmias and Treatments
- Autoimmune and Inflammatory Disorders Research
- Aortic Disease and Treatment Approaches
- Cardiac pacing and defibrillation studies
- Health Systems, Economic Evaluations, Quality of Life
- Viral Infections and Vectors
- Lipoproteins and Cardiovascular Health
- Pharmaceutical Economics and Policy
- Cardiovascular Function and Risk Factors
- Venous Thromboembolism Diagnosis and Management
- Cardiac Arrest and Resuscitation
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes
- Vector-borne infectious diseases
Nantes Université
2019-2025
Inserm
2025
Institut du Thorax
2022-2025
Centre National de la Recherche Scientifique
2025
Centre Hospitalier Universitaire de Nantes
2022-2023
- According to international guidelines, lowering LDL-cholesterol is the cornerstone of atherosclerotic cardiovascular disease (ASCVD) prevention. However, observational studies have identified current gaps in implementation lipid-lowering therapy (LLT). This whole-population study aimed evaluate prevalence and determinants LLT use ASCVD patients. Using national health data system, all French adults with established between 2012 2021 were using specific ICD-10 and/or procedure codes. was...
The objective was to investigate the outcomes of concomitant venoarterial extracorporeal membrane oxygenation (ECMO) and left ventricular unloading with Impella (ECPELLA) compared ECMO alone treat patients affected by cardiogenic shock. Data from needing mechanical circulatory support 4 international centers were analyzed. Of 438 included, ECPELLA adopted in 319 (72.8%) 119 (27.2%) patients, respectively. Propensity score matching analysis identified 95 pairs. In matched cohort, 30-day...
Abstract Rescue transcatheter aortic valve replacement (TAVR) in patients with cardiogenic shock is challenging, and there limited literature on these critical patients. The aim of this study was to determine the characteristics outcomes undergoing TAVR, feasibility safety procedure, 1‐year mortality factors. Thirty‐eight severe disease admitted two French hospitals from 2015 2019 were included. critical, 78.9% them had a left ventricular ejection fraction <30%, all received inotropic...
Ventricular septal defect (VSD) is a rare but severe complication of myocardial infarction (MI). Temporary mechanical circulatory support (MCS) can be used as bridge to VSD closure, heart transplantation, or ventricular assist device. We describe the use Impella device in this context based on multicenter European retrospective registry (17 centers responded). Twenty-eight post-MI patients were included (Impella 2.5 for 1 patient, CP 20, 5.0 5, and unknown 2). All cardiogenic shock with...
Large datasets of transcatheter aortic valve implantation (TAVI) for pure regurgitation (PAVR) are scarce.
Transcatheter aortic valve replacement is currently used off-label for noncalcified regurgitation and therefore restricted to selected cases. In this setting we describe a rare complication of Sapien 3 (Edwards Lifesciences, Irvine, California) embolization from the left ventricle descending aorta. Given their technical challenges, such procedures require specific considerations management. (Level Difficulty: Advanced.)
In recent years, several improvements have enhanced the procedures for transcatheter aortic valve replacement (TAVR). These include vascular puncture with ultrasound guidance, radial access as a secondary safety approach and noninvasive left ventricular pacing using direct wire (DWP) technique.1Burzotta F. Aurigemma C. Romagnoli E. et al.A less-invasive totally-endovascular (LITE) technique trans-femoral replacement.Catheter Cardiovasc Interv. 2020; 96:...
Abstract Funding Acknowledgements Type of funding sources: None. Backgroud Ventricular septal defect (VSD), is a rare but fatal complication myocardial infarction (MI) associated with high early mortality. Temporary mechanical circulatory support (t-MCS) any type can be used to stabilize the patient as bridge surgical or percutaneous closure, heart transplantation long-term ventricular assist device, low level evidence. The Impella® device trans-valvular aortic axial pump inserted surgically...
We report the case of a 40-year-old veterinary surgeon who was admitted for spiking fevers, arthralgia, and complete atrioventricular block. Tests revealed an inflammatory syndrome, hepatic cytolysis, neutrophilic leukocytosis, increased troponin levels. Cardiac magnetic resonance imaging showed small myocarditis but no tissue abnormality on conduction pathways. In absence evidence-based infection favorable evolution under broad spectrum antibiotherapy, adult-onset Still's disease suspected...
Bifurcation lesions in coronary arteries are complex to treat with stents, which not designed for that purpose and can be unproperly deployed. Moreover, devices constantly evolving, so angioplasty techniques.The aim of this study was determine the performances different stents treatment bifurcation using re-proximal optimization technique (rePOT).Eleven stent platforms were evaluated: Xience Sierra (Abbott), Alpine Synergy (Boston), Coroflex Isar (Bbraun), Cobra PzF (Celonova), Ultimaster...
Report contemporary outcomes in patients included the Mitragister registry and treated with transcatheter mitral valve implantation for failed surgical annuloplasty rings or deteriorated bioprosthesis.Midterm survival rates have been reported, but little is known about morbimortality endpoints.The primary safety outcome was technical success rate. The efficacy composite endpoint a of cardiovascular mortality heart failure hospitalizations.From 2016 to 2021, 102 (median age: 81 [74;84] years,...
Background and Aim The mortality rate of patients with post-myocardial infarction (MI) ventricular septal defects (VSDs) is high, the benefit surgery unclear. We aimed to investigate management outcomes post-MI VSD over a 10-year period in large cohort. Methods Data admitted three French university hospitals from 2008 2019 were examined. characteristics those who underwent compared received medical treatment. Mortality risk factors, survival curves, at 30 days 1 year after treatment...